Early research (Phase 1)Study completedNCT02423525What this trial is testingSafety Study of Afatinib for Brain CancerWho this might be right forBrain Cancer Santosh Kesari 24
Testing effectiveness (Phase 2)Study completedNCT00995007What this trial is testingPhase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade GliomasWho this might be right forGlioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more National Cancer Institute (NCI) 112
Testing effectiveness (Phase 2)Study completedNCT00024570What this trial is testingInterstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant GliomaWho this might be right forMalignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more INSYS Therapeutics Inc 60
Testing effectiveness (Phase 2)Study completedNCT00049127What this trial is testingImatinib Mesylate in Treating Patients With Recurrent Brain TumorWho this might be right forAdult Anaplastic OligodendrogliomaAdult Mixed GliomaAdult Oligodendroglioma+1 more Alliance for Clinical Trials in Oncology 64
Early research (Phase 1)Study completedNCT00734682What this trial is testingA Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade GliomasWho this might be right forGlioblastomaGliosarcomaAnaplastic Astrocytoma+1 more University of California, San Francisco 34
Testing effectiveness (Phase 2)Ended earlyNCT00062504What this trial is testingPhase 2 Trial Using Talampanel in Patients With Recurrent High Grade GliomasWho this might be right forGlioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more Teva Branded Pharmaceutical Products R&D, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00041587What this trial is testingPre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant GliomaWho this might be right forMalignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more INSYS Therapeutics Inc 80
Testing effectiveness (Phase 2)Study completedNCT00008008What this trial is testingThiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Herbert Irving Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00165360What this trial is testingProlonged Daily Temozolomide for Low-Grade GliomaWho this might be right forGliomaAstrocytomaOligodendroglioma Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)Ended earlyNCT02023905What this trial is testingEverolimus With and Without Temozolomide in Adult Low Grade GliomaWho this might be right forLow Grade GliomaWorld Health Organization (WHO) Grade II AstrocytomasOligodendrogliomas+1 more University of California, San Francisco 27
Testing effectiveness (Phase 2)Study completedNCT00362570What this trial is testingTemozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed OligoastrocytomaWho this might be right forOligoastrocytoma, MixedAnaplastic Oligodendroglioma Ohio State University Comprehensive Cancer Center 1
Early research (Phase 1)Looking for participantsNCT03152318What this trial is testingThe Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2Who this might be right forMalignant Glioma of BrainAstrocytomaMalignant Astrocytoma+11 more Dana-Farber Cancer Institute 62
Early research (Phase 1)Study completedNCT00064779What this trial is testingImaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant GliomaWho this might be right forMalignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more INSYS Therapeutics Inc 18
Testing effectiveness (Phase 2)Ended earlyNCT02372409What this trial is testingUsing MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain TumorsWho this might be right forGliomaPilocytic AstrocytomaAnaplastic Astrocytoma+6 more Washington University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT00400816What this trial is testingTemozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed OligoastrocytomaWho this might be right forCentral Nervous System TumorsBrain Tumor The Cleveland Clinic 29
Testing effectiveness (Phase 2)Study completedNCT00003372What this trial is testingTopotecan in Treating Patients With Recurrent Brain TumorsWho this might be right forBrain and Central Nervous System Tumors NCIC Clinical Trials Group 17
Early research (Phase 1)Study completedNCT00526812What this trial is testingA Safety Study of RTA 744 in Patients With Recurrent High-Grade GliomasWho this might be right forGlioma Biogen 54
Testing effectiveness (Phase 2)Study completedNCT00033280What this trial is testingTemozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic OligoastrocytomasWho this might be right forBrain and Central Nervous System Tumors Radiation Therapy Oncology Group 42
Early research (Phase 1)Study completedNCT00024557What this trial is testingHistologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma PatientsWho this might be right forMalignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more INSYS Therapeutics Inc 40
Testing effectiveness (Phase 2)Study completedNCT00667394What this trial is testingTandutinib Plus Bevacizumab to Treat Recurrent Brain TumorsWho this might be right forGlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more National Cancer Institute (NCI) 42